Vir Biotechnology, Inc. logo VIR - Vir Biotechnology, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 10
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $21.14 DETAILS
HIGH: $30.00
LOW: $18.00
MEDIAN: $20.00
CONSENSUS: $21.14
UPSIDE: 130.03%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue 68.6 74.2 86.2 1,615.8 1,095.4 67.2 0.7 0.9 0.1
Cost of Revenue 11.7 478.6 572.8 621.0 513.9 0 0 100.2 62.5
Gross Profit 56.9 (404.4) (486.6) 994.8 581.5 67.2 0.7 (99.4) (62.4)
Operating Expenses
R&D Expenses 432.8 506.5 579.7 474.6 448.0 302.4 148.5 100.2 62.5
SG&A Expenses 92.1 0 0 0 0 70.9 37.6 29.1 21.7
Other Expenses 0 (323.8) (382.1) (312.9) (287.2) (9.1) (7.4) (0.2) 0.1
Operating Expenses 524.9 182.7 197.7 161.8 160.8 364.2 178.7 119.6 81.6
Operating Income
Operating Income (468.0) (587.2) (684.3) 833.1 420.8 (297.0) (178.0) (118.7) (81.5)
Interest Expense 0 0 0 0 0 0 0 0 0
Interest Income 40.2 71.8 87.0 28.1 0.4 2.8 8.5 2.5 0.6
Profitability
EBITDA (426.1) (508.9) (641.6) 839.9 426.6 (291.5) (173.5) (115.9) (81.1)
EBIT (437.8) (523.5) (661.1) 833.1 420.8 (297.0) (178.0) (118.7) (81.5)
Income Before Tax (437.8) (523.1) (628.2) 754.3 549.8 (298.6) (174.5) (116.4) (80.8)
Income Tax Expense 0.2 (1.1) (13.1) 238.4 21.2 0.1 0.2 (0.5) (10.9)
Net Income (438.0) (522.0) (615.1) 515.8 528.6 (298.7) (174.7) (115.9) (69.9)
Per Share Data
EPS (Basic) -3.16 -3.83 -4.59 3.89 4.07 -2.51 -1.62 -1.20 -10.02
EPS (Diluted) -3.16 -3.83 -4.59 3.83 3.96 -2.51 -1.62 -1.20 -10.02
Shares Outstanding 138.5 136.2 134.1 132.6 129.9 119.2 107.6 96.9 7.0
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017
Current Assets
Cash & Cash Equivalents 234.1 222.9 241.6 848.6 347.8 436.6 109.3 47.6 187.9
Short-Term Investments 228.8 682.4 1,280.8 1,553.4 360.3 300.3 274.1 50.8 0
Net Receivables 3.6 0 0 0 773.1 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0
Other Current Assets 47.6 137.1 65.8 59.2 8.6 8.0 6.2 10.8 0
Total Current Assets 514.1 1,042.5 1,588.2 2,519.1 1,562.8 772.4 403.0 117.8 192.3
Non-Current Assets
Property, Plant & Equipment 117.7 122.9 167.2 188.2 130.1 79.9 16.3 12.3 5.1
Goodwill 16.9 16.9 16.9 16.9 16.9 16.9 16.9 16.9 16.9
Intangible Assets 7.8 8.1 22.6 32.8 33.3 33.8 35.7 36.9 35.9
Long-Term Investments 314.6 190.0 105.3 23.9 201.4 0 24.3 7.7 1.0
Other Non-Current Assets 31.7 18.4 18.9 (228.5) 9.8 15.7 15.8 7.7 1.3
Total Non-Current Assets 488.7 356.3 330.8 283.0 391.4 146.4 109.0 73.8 59.2
Total Assets 1,002.8 1,398.8 1,919.1 2,802.1 1,954.3 918.8 512.1 191.6 251.6
Current Liabilities
Account Payables 9.8 5.1 6.3 6.4 6.5 5.1 5.9 6.5 4.9
Short-Term Debt 8.8 0 0 0 0 0 0 0 0
Deferred Revenue 0 12.6 64.9 15.5 98.2 6.5 6.2 8.8 0
Other Current Liabilities 74.2 16.1 9.4 7.7 0 10.6 22.1 22.0 0
Total Current Liabilities 92.8 119.7 175.4 511.0 341.2 99.1 59.2 39.9 12.4
Non-Current Liabilities
Long-Term Debt 89.1 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 3.3 18.4 3.3 3.3 3.3 3.3
Other Non-Current Liabilities (33.4) 38.6 40.2 32.8 25.4 29.2 12.9 10.8 10.4
Total Non-Current Liabilities 144.7 128.8 153.4 213.1 181.2 102.8 28.9 330.9 308.0
Total Liabilities 237.5 248.4 328.8 724.1 522.4 201.9 88.1 370.8 320.5
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (1,197.8) (759.8) (237.8) 377.2 (138.6) (667.2) (368.5) (193.8) (78.0)
Accumulated Other Comprehensive Income (2.1) (1.7) (0.8) (9.1) (1.1) (1.3) (0.6) (0.0) (292.5)
Total Stockholders' Equity 765.3 1,150.4 1,590.2 2,078.0 1,431.8 716.9 423.9 (179.2) (68.9)
Total Liabilities & Equity 1,002.8 1,398.8 1,919.1 2,802.1 1,954.3 918.8 512.1 191.6 251.6
Debt Metrics
Total Debt 186.9 97.9 124.5 128.0 137.5 70.2 0.2 10.1 0
Net Debt (47.2) (125.1) (117.0) (720.7) (210.3) (366.4) (109.1) (37.5) (187.9)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017
Operating Activities
Net Income (438.0) (522.0) (615.1) 515.8 528.6 (298.7) (174.7) (115.9) (69.9)
Depreciation & Amortization 21.2 14.6 19.5 6.8 5.8 5.4 4.5 2.8 0.4
Stock-Based Compensation 49.1 78.5 0 102.1 83.8 27.6 8.7 5.1 4.8
Change in Working Capital (22.4) (84.0) (304.6) 665.4 (628.4) 29.5 8.2 12.5 4.9
Other Non-Cash Items (1.6) 69.5 122.5 388.4 (52.6) 45.2 23.6 2.0 4.3
Operating Cash Flow (391.8) (446.4) (778.8) 1,663.3 (47.6) (190.9) (129.6) (94.1) (66.4)
Investing Activities
Capital Expenditure (4.8) (7.3) (21.6) (68.0) (21.8) (6.5) (8.9) (8.2) (2.7)
Acquisitions 0.3 3.4 0.1 0 140.8 0 0 0.0 (27.3)
Purchases of Investments (886.3) (1,235.3) (2,016.2) (1,477.0) (420.2) (403.8) (643.9) (123.1) 0
Sales/Maturities of Investments 1,201.3 1,738.6 2,202.4 351.5 301.2 400.3 396.7 72.6 0
Other Investing Activities 0 0 0 0 (140.8) 0.2 0 (1.7) 0
Investing Cash Flow 310.4 499.4 164.7 (1,193.5) (140.8) (9.9) (256.2) (60.4) (30.0)
Financing Activities
Net Debt Issuance (0.4) (0.2) (0.3) (0.3) (0.3) (0.2) 4.4 0 0
Stock Repurchased 0 0 0 0 0 0 (0.0) 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 (0.1) 6.6 15.4 (0.2) 1.1 0.6 0
Financing Cash Flow 3.8 4.4 7.4 34.8 100.3 529.5 449.2 25.0 271.2
Cash Position
Net Change in Cash (77.6) 57.4 (606.5) 504.6 (88.1) 328.7 63.5 (129.6) 174.8
Cash at Beginning 318.7 261.3 861.3 363.4 451.5 122.8 59.4 188.9 14.1
Cash at End 241.1 318.7 254.8 868.0 363.4 451.5 122.8 59.4 188.9
Free Cash Flow (396.6) (453.7) (800.4) 1,595.2 (69.4) (197.5) (138.6) (102.3) (69.1)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017
Income Statement
Revenue 68.6 74.2 86.2 1,615.8 1,095.4 67.2 0.7 0.9 0.1
Gross Profit 56.9 (404.4) (486.6) 994.8 581.5 67.2 0.7 (99.4) (62.4)
Operating Income (468.0) (587.2) (684.3) 833.1 420.8 (297.0) (178.0) (118.7) (81.5)
Net Income (438.0) (522.0) (615.1) 515.8 528.6 (298.7) (174.7) (115.9) (69.9)
EPS (Diluted) -3.16 -3.83 -4.59 3.83 3.96 -2.51 -1.62 -1.20 -10.02
Balance Sheet
Cash & Equivalents 234.1 222.9 241.6 848.6 347.8 436.6 109.3 47.6 187.9
Total Assets 1,002.8 1,398.8 1,919.1 2,802.1 1,954.3 918.8 512.1 191.6 251.6
Total Debt 186.9 97.9 124.5 128.0 137.5 70.2 0.2 10.1 0
Stockholders' Equity 765.3 1,150.4 1,590.2 2,078.0 1,431.8 716.9 423.9 (179.2) (68.9)
Cash Flow
Operating Cash Flow (391.8) (446.4) (778.8) 1,663.3 (47.6) (190.9) (129.6) (94.1) (66.4)
Capital Expenditure (4.8) (7.3) (21.6) (68.0) (21.8) (6.5) (8.9) (8.2) (2.7)
Free Cash Flow (396.6) (453.7) (800.4) 1,595.2 (69.4) (197.5) (138.6) (102.3) (69.1)